Renal function and rate of hip bone loss in older men: The Osteoporotic Fractures in Men Study

Osteoporosis International

Volumn 19, Issue 11, 2008, Pages 1549-1556

  Ishani, A ^a,b,h   Paudel, M ^a   Taylor, B C ^a,b   Barrett Connor, E ^d   Jamal, S ^e   Canales, M ^b   Steffes, M ^c   Fink, H A ^a,b   Orwoll, E ^f   Cummings, S R ^g   Ensrud, K E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^h NONE   (United States)

Author keywords

Chronic kidney disease; Cystatin C; Glomerular filtration rate; Osteoporosis; Population studies

Indexed keywords

CREATININE; CYSTATIN C;

ARTICLE; BONE DENSITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET; FRAGILITY FRACTURE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; CREATININE; CYSTATIN C; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HIP JOINT; HUMANS; KIDNEY FUNCTION TESTS; MALE; OSTEOPOROSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 53549095197     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0608-0     Document Type: Article

References (38)

1. CO Stehman-Breen D Sherrard A Walker R Sadler A Alem J Lindberg 1999 Racial differences in bone mineral density and bone loss among end-stage renal disease patients Am J Kidney Dis 33 941 946
2. AM Alem DJ Sherrard DL Gillen NS Weiss SA Beresford SR Heckbert C Wong C Stehman-Breen 2000 Increased risk of hip fracture among patients with end-stage renal disease Kidney Int 58 396 399
3. MA Fontaine A Albert B Dubois A Saint-Remy G Rorive 2000 Fracture and bone mineral density in hemodialysis patients Clin Nephrol 54 218 226
4. SK Jassal D von Muhlen E Barrett-Connor 2007 Measures of Renal Function, BMD, Bone Loss, and Osteoporotic Fracture in Older Adults: The Rancho Bernardo Study J Bone Miner Res 22 203 210
5. D Fliser E Ritz 2001 Serum cystatin C concentration as a marker of renal dysfunction in the elderly Am J Kidney Dis 37 79 83
6. LF Fried MG Shlipak C Stehman-Breen A Mittalhenkle S Seliger M Sarnak J Robbins D Siscovick TB Harris AB Newman JA Cauley 2006 Kidney function predicts the rate of bone loss in older individuals: the Cardiovascular Health Study J Gerontol A Biol Sci Med Sci 61 743 748
7. E Orwoll JB Blank E Barrett-Connor J Cauley S Cummings K Ensrud C Lewis PM Cawthon R Marcus LM Marshall J McGowan K Phipps S Sherman ML Stefanick K Stone 2005 Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-a large observational study of the determinants of fracture in older men Contemp Clin Trials 26 569 585
8. JB Blank PM Cawthon ML Carrion-Petersen L Harper JP Johnson E Mitson RR Delay 2005 Overview of recruitment for the osteoporotic fractures in men study (MrOS) Contemp Clin Trials 26 557 568
9. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31 41
10. D DuBois EF Dubois 1916 A formula to estimate the approximate surface area if height and weight be known Arch Intern Med 17 863 871
11. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van LF. Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine Values. Clin Chem 2007
12. RA Washburn JL Ficker 1999 Physical Activity Scale for the Elderly (PASE): the relationship with activity measured by a portable accelerometer J Sports Med Phys Fitness 39 336 340
13. EJ Bassey AH Short 1990 A new method for measuring power output in a single leg extension: feasibility, reliability and validity Eur J Appl Physiol Occup Physiol 60 385 390
14. GM Berlyne J Ben Ari A Kushelevsky A Idelman D Galinsky M Hirsch R Shainkin R Yagil M Zlotnik 1975 The aetiology of senile osteoporosis: secondary hyperparathyroidism due to renal failure Q J Med 44 505 521
15. ML Bianchi G Colantonio A Montesano C Trevisan S Ortolani R Rossi G Buccianti 1992 Bone mass status in different degrees of chronic renal failure Bone 13 225 228
16. JR Buchanan CA Myers RB Greer III 1988 Effect of declining renal function on bone density in aging women Calcif Tissue Int 43 1 6
17. M Rix H Andreassen P Eskildsen B Langdahl K Olgaard 1999 Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure Kidney Int 56 1084 1093
18. SS Sherman JD Tobin BW Hollis CM Gundberg TA Roy CC Plato 1992 Biochemical parameters associated with low bone density in healthy men and women J Bone Miner Res 7 1123 1130
19. ER Yendt M Cohanim S Jarzylo G Jones G Rosenberg 1991 Bone mass is related to creatinine clearance in normal elderly women J Bone Miner Res 6 1043 1050
20. CY Hsu SR Cummings CE McCulloch GM Chertow 2002 Bone mineral density is not diminished by mild to moderate chronic renal insufficiency Kidney Int 61 1814 1820
21. TL Nickolas DJ McMahon E Shane 2006 Relationship between moderate to severe kidney disease and hip fracture in the United States J Am Soc Nephrol 17 3223 3232
22. KE Ensrud LY Lui BC Taylor A Ishani MG Shlipak KL Stone JA Cauley SA Jamal DM Antoniucci SR Cummings 2007 Renal function and risk of hip and vertebral fractures in older women Arch Intern Med 167 133 139
23. LF Fried ML Biggs MG Shlipak S Seliger B Kestenbaum C Stehman-Breen M Sarnak D Siscovick T Harris J Cauley AB Newman J Robbins 2007 Association of kidney function with incident hip fracture in older adults J Am Soc Nephrol 18 282 286
24. TO Pitts BH Piraino R Mitro TC Chen GV Segre A Greenberg JB Puschett 1988 Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure J Clin Endocrinol Metab 67 876 881
25. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266
26. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-201
27. CR Keller MC Odden LF Fried AB Newman S Angleman CA Green SR Cummings TB Harris MG Shlipak 2007 Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study Kidney Int 71 239 244
28. V Menon MJ Sarnak T Greene X Wang AA Pereira GJ Beck JW Kusek J Selhub AJ Collins AS Levey MG Shlipak 2006 Relationship between homocysteine and mortality in chronic kidney disease Circulation 113 1572 1577
29. LM Salamone T Whiteside D Friberg RS Epstein LH Kuller JA Cauley 1998 Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women Calcif Tissue Int 63 466 470
30. H Refsum E Nurk AD Smith PM Ueland CG Gjesdal I Bjelland A Tverdal GS Tell O Nygard SE Vollset 2006 The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease J Nutr 136 1731S 1740S
31. L Norlund G Fex J Lanke SH Von JE Nilsson H Leksell A Grubb 1997 Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio Scand J Clin Lab Invest 57 463 470
32. MG Shlipak MJ Sarnak R Katz LF Fried SL Seliger AB Newman DS Siscovick C Stehman-Breen 2005 Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 2049 2060
33. E Wasen R Isoaho K Mattila T Vahlberg SL Kivela K Irjala 2004 Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C J Intern Med 256 70 78
34. V Menon MG Shlipak X Wang J Coresh T Greene L Stevens JW Kusek GJ Beck AJ Collins AS Levey MJ Sarnak 2007 Cystatin C as a risk factor for outcomes in chronic kidney disease Ann Intern Med 147 19 27
35. MC Odden GM Chertow LF Fried AB Newman S Connelly S Angleman TB Harris EM Simonsick MG Shlipak 2006 Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study Am J Epidemiol 164 1180 1189
36. MG Shlipak R Katz MJ Sarnak LF Fried AB Newman C Stehman-Breen SL Seliger B Kestenbaum B Psaty RP Tracy DS Siscovick 2006 Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Ann Intern Med 145 237 246
37. AM O'Hare AB Newman R Katz LF Fried CO Stehman-Breen SL Seliger DS Siscovick MG Shlipak 2005 Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study Arch Intern Med 165 2666 2670
38. LF Fried R Katz MJ Sarnak MG Shlipak PH Chaves NS Jenny C Stehman-Breen D Gillen AJ Bleyer C Hirsch D Siscovick AB Newman 2005 Kidney function as a predictor of noncardiovascular mortality J Am Soc Nephrol 16 3728 3735